RxDoctor Payments Data

Anna Seegars, APRN

Family · Spartanburg, SCNPI 1124643812

Payments from drug & device makers

$932in general payments, 2019–2025

Across 69 payments — averaging $13.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$240
  • Teva Pharmaceuticals USA, Inc.$195
  • E.r. Squibb & Sons, L.L.C.$179
  • Alkermes, Inc.$94
  • Johnson & Johnson$66
  • Otsuka America Pharmaceutical, Inc.$58
  • plus $100 from 3 others

What the payments were for

  • Food & beverage$932100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$932 in reported general payments places this provider in the 65th percentile of 3,248 family providers in South Carolina.

See all family providers in South Carolina

Medicare billing

Part B allowed, 2024
$14,448
Medicare patients
62
Services billed
411

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate253$799,786
Invega TrinzaPaliperidone Palmitate40$346,810
Abilify MaintenaAripiprazole63$175,214
UzedyRisperidone34$121,201
Risperdal ConstaRisperidone Microspheres35$76,400
RexultiBrexpiprazole28$42,110
Risperidone ErRisperidone Microspheres14$27,425
Haloperidol Decanoate139$10,450
Aripiprazole160$10,314
Paliperidone ErPaliperidone71$9,952
Divalproex Sodium ErDivalproex Sodium134$5,321
Benztropine Mesylate300$4,544
Divalproex Sodium31$4,446
Olanzapine119$3,530
Ziprasidone Hcl30$3,487

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna, Invega Trinza, Risperdal Consta$66$1,222,996328 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti$58$217,32391 claims
Teva Pharmaceuticals USA, Inc.Uzedy$195$121,20134 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,248 family providers in South Carolina.

Other family in Spartanburg

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →